ALFA Finder| Order from | LIB Therapeutics Inc. |
|---|
BSE filing, NSE: SUNPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Sun Pharmaceutical Industries Ltd: key numbers
- Share price
- ₹1,902.30
- Market cap
- ₹4,56,426 Cr
- Revenue (annual)
- ₹58,462 Cr
- Net profit (annual)
- ₹11,479 Cr
- P/E (TTM)
- 41.6×Sector 43.8×
- Promoter holding
- 52.68%-1.80% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sun Pharmaceutical Industries Ltd
All →Sun Pharmaceutical Industries Price Movement Clarification
Sun Pharma said a 30 October 2026 news report concerned August 2026 developments, not new events. It confirmed no undisclosed material information explains the share price movement.
Sun Pharmaceutical Industries Annual General Meeting
Sun Pharma's postal ballot passed all seven special resolutions, including ESOP 2026 approval and borrowing and security limits. No monetary transaction is stated.
Sun Pharmaceutical Industries Earnings Call Transcript: Key Takeaways
Sun Pharma delivered resilient double-digit revenue growth despite U.S. specialty headwinds, masking underlying margin pressure from lower Lenalidomide sales.
Sun Pharmaceutical Industries Other Announcement
Sun Pharma's board appointed Deloitte as Statutory Auditors under mandatory rotation, effective from the FY 2026-27 AGM. This follows SRBC & CO's second five-year term completion.
Sun Pharmaceutical Industries Q2 FY27 Results: Net Profit ₹1,995 Cr, Down 36.2% YoY
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹16,199 Cr (+11.9% YoY) and net profit of ₹1,995 Cr (-36.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,995 Cr · -36.2% YoY
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
Other partnership announcements
All →delaPlex Partnership
Delaplex Limited announced a strategic partnership with UKG to deliver workforce management consulting and implementation across India and Asia-Pacific. No monetary value or financial impact was disclosed.
Annu Projects Partnership
Annu Projects signed an MoU with GEIE Solar Products to supply materials for a JVVNL rooftop solar project. No Annu-specific consideration is stated.
Odyssey Corporation Partnership
Odyssey Corporation signed an MOU with Sinton Agribid Trading for agricultural commodity trading. The partner returns the invested capital plus a minimum profit and bears any shortfall.
Adarsh Plant Protect Partnership
Adarsh Plant Protect signed an MoU with Rapid Group and Smart Solar to form a contractual joint venture. The venture targets Nepal cook stove supply tenders.
Everest Kanto Cylinder Partnership
Everest Kanto's subsidiary EKC Egypt signed an MoU with CARGAS to study CNG transport unit manufacturing. No monetary value or orders have been committed yet.
- Execution
- One-year framework MoU, renewable for additional periods
Blue Cloud Softech Solutions Partnership
Blue Cloud Softech signed an MoU with Ghana-based Kasten Development to explore business development in Ghana and Africa. No monetary value was disclosed.